Likewise, GalNAcT6 was found to function as an independent prognostic marker in pancreatic cancer, although both GalNAcT3 and GalNAcT6 were co-expressed in a cohort of pancreatic cancer cases [40]. This evidence concerns the gene GALNT6 and familial pancreatic carcinoma.